openPR Logo
Press release

PFS Development – challenges and solutions, Pre-Filled Syringes East Coast is the place to debate

02-01-2019 03:45 PM CET | Health & Medicine

Press release from: SMi Group

Pre-Filled Syringes East Coast Conference 2019

Pre-Filled Syringes East Coast Conference 2019

Despite lucrative opportunities in the PFS industry, there are a few ongoing challenges that the key-leaders battle to overcome, including human factor considerations, new laws, user interface considerations and patient safety. SMi’s Pre-Filled Syringes East Coast Conference (8 - 9 April, Boston, US) is a place to debate these issues, engage with experts and determine strategy.

One of the main features of the event will be what the future of Pre-Filled Syringes and what the drivers will be.

Key sessions include:

Design device strategy for successful implementation of connected devices
- Case study of i-smart, a smart blister tracking device
- Connectivity and data strategy for choosing the right programs
- Setting up the all-important device development programs
- Process of reorganizing funding and financing for device development platforms
Cedric Gysel, Health Care Solutions Design Manager, Johnson & Johnson Design

Early stage device development and understanding cyber security
- De-risk evaluation in terms of early stage device development
- Digital estimations in terms of challenges for patience use and product integrity
- Case study evidence to advise against rushing digital tools to the market and how to ensure they are robust enough
- Advice on cyber security with new devices and the challenges within field
Michael Song, Sr. Manager, Drug Delivery and Device Development, MedImmune

Interactive workshops on April 10th will provide insights into:
• Glass and Polymer – Two Established Materials for Primary Containers – Identify the Best Option
Lead by: Gerressheimer
• Preparing for a Pre-Submission Meeting
Lead by: PAREXEL

More debates, key-note presentations and case-studies are awaiting participants of the Pre-Filled Syringes East Coast Conference – view complete agenda at http://www.pfsamericas.com

----------------------------------------------------------
Book by February 28th to SAVE $100
----------------------------------------------------------

Sponsored by:
Aptar Pharma | CSS (CONNECTICUT SPRING & STAMPING) | Harro Höfliger | LONSTROFF | MITSUBISHI GAS CHEMICAL | Owen Mumford | Polyplastics | SCHOTT | Steri-Tek | SUMITOMO RUBBER INDUSTRIES | 3P Innovation | West Pharmaceutical Services | ZEON | ZwickRoell

Limited exhibition opportunities at this sell-out event, get in touch with Alia Malick on +44 (0)20 7827 6156 to discuss how to raise your profile in the most efficient and dynamic way

Twitter - follow #smipfsusa

Pre-Filled Syringes East Coast Conference | April 8 - 9, 2019 | Boston, USA

---- END ----

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Registered & Head Office: SMi Group Ltd, India House, 45 Curlew Street, London, SE1 2ND
Contact Neill Howard on email: nhoward@smi-online.co.uk

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PFS Development – challenges and solutions, Pre-Filled Syringes East Coast is the place to debate here

News-ID: 1554508 • Views: 503

More Releases from SMi Group

Darren Green, GSK, conference chair invitation to attend 3rd Annual AI in Drug D …
SMi Reports: Conference Chairman Darren Green from GSK personally invites you the 3rd Annual AI in Drug Discovery Conference taking place on 14th and 15th March 2022 in London, UK. The conference will have a focus on case studies from leading pharma and biotech firms, as well as a exploring the latest innovations in machine learning for enhancing discovery pipelines. Darren Green, Director of Computational Chemistry at GSK will be chairing at
Registration is open for SMi’s 5th Annual Pharmaceutical Microbiology East Coa …
SMi Group reports: The 5th Annual Pharmaceutical Microbiology East Coast Conference is set to return in April 2022 with a key focus existing methods and novel tools in microbial control to assure continuity in product quality and patient safety. SMi Group is delighted to announce the 5th Annual Pharmaceutical Microbiology East Coast Conference, taking place on the 27th and 28th April 2022 in Boston, USA. The 2022 Conference theme is
SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Confer …
SMi Reports: SMi Group have made the decision to open the microbiology conference and workshops to all microbiologists by transforming it into a virtual-remote online access event only on 17th and 18th January 2022. SMi’s 10th Annual Pharmaceutical Microbiology UK Conference will no longer take place in London, UK. Instead, the conference is taking place on 17 and 18 January 2022 and will open its doors to a global audience delivering
Co-chairs Philip Hewitt and Stefan Pryzyborski, invitation to join SMi’s 5th A …
SMi Group reports: Co-Chairs, Philip Hewitt and Stefan Pryzyborski for SMi’s 5th Annual 3D Cell Culture invite industry professionals to join the conference in February 2022. Philip Hewitt, Global Head of Early Investigative Toxicology, Merck and Stefan Przyborski, Professor in Cell Technology, Durham University invite industry professionals by releasing invite letter to join SMi’s 5th Annual 3D Cell Culture Conference 2022. This event will convene on February 9th – 10th 2022,

All 5 Releases


More Releases for Syringes

Benefits of Prefilled Syringes over Traditional Vials and Syringes Driving Prefi …
In 2017, the global prefilled syringes market reached $4.7 billion and is projected to register an 8.3% CAGR during the forecast period (2018-2023). The market is growing because of the extensive pipeline of injectable drugs, rising demand for injectable pharmaceutical products, expanding pharmaceutical industry, increasing prevalence of chronic and lifestyle associated diseases, surging requirement for point-of-care administration, benefits of prefilled syringes over conventional vial and syringe packaging systems, regulations associated
Syringes and Needles Market Research Study Analysed in New Report 2019 | Disposa …
The research study offers powerful guidelines for market players to compete well against other participants operating in the global Syringes and Needles market. It brings to light crucial market dynamics including drivers, challenges, restraints, trends, and opportunities. Readers are provided with detailed qualitative and quantitative analysis, PESTLE analysis, absolute dollar opportunity analysis, and Porter’s Five Forces analysis that focus on various aspects of the global Syringes and Needles Market. The
Auto Disable Syringes Market
According to a new report published by Data Bridge Market Research The global auto disable syringes market accounted to USD 8.0 billion in 2016 growing at a CAGR of 10.0% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Get Free Market Sample Report @ http://bit.ly/2D6yKaO Key
Market Research on Prefilled Syringes Market 2021
The Global Prefilled Syringes Market was worth USD 3.6 billion in 2016 and estimated to grow at a CAGR of 10.7%, to reach USD 6.1 billion by 2021. These syringes are very effective in self-administration of drugs and the demand for these syringes has been rising over the past few years. This format of parenteral drug delivery system is being adopted by growing number of healthcare facilities. Browse more details @
Global Dental Syringes Market By Product (Non disposable Dental Syringes) Type ( …
Global Dental Syringes Market, By Product (Non disposable Dental Syringes, Disposable Dental Syringes, Disposable Dental Syringes), Type (Aspirating Dental Syringes, Non Aspirating Dental Syringes), Material (Metallic Dental Syringes, Plastic Dental Syringes), Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) This report consists of below pages: • No of pages : 350 • No of Figures: 60 • No of Tables:250 Request for Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-dental-syringes-market The global dental syringes market accounted
Prefilled Syringes Market
Parenteral drugs are the second most preferred type of drugs after oral solid dosage forms and also holds second largest market share in terms of revenue in overall pharmaceutical market. Various benefits such as ease in administration, better patient compliance and 100% bioavailability are the few important factors that are expected to favor growth of the prefilled syringes market over the forecast period (2016–2024). Prefilled syringes segment is the one